Stockholders' Deficiency (Details Narrative) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Aggregate shares			$ 3,501,975
Shares price			1.00%
Beneficial Conversion Feature			202,305
Common Stock Issuable	1,326,700		1,326,700
Beneficial Conversion Feature Related to Incremental Shares	0		1,330,417
Weighted Average Fair Value	$ 6.99		$ 6.99
Selling, General And Administrative Expenses	13,799	290,221	326,243	549,630
Stock-Based Compensation Expense				1,987,548
Weighted Average Remaining Period				2 years 1 month 6 days
Common Stock Warrant Issued			9,734,747
Warrants Exercise Purchase			16,171,952
Warrants Exercise Price Per Share			$ 0.25
Salary expense	87,500		175,000
Stock Options Granted	145.00%		157.00%
Series B Preferred Stock [Member]
Preferred Stock Contractual Dividends	69,840		139,689
Preferred Stock Recorded Shares	65,271		130,542
Series C Preferred Stock [Member]
Preferred Stock Deemed Dividend	92,916		185,832
Stock Warrants [Member]
Weighted Average Fair Value	$ 0.71	$ 0	$ 1.36	$ 0
Selling, General And Administrative Expenses	9,587	0	514,364	0
Stock-Based Compensation Expense			$ 664,724
Weighted Average Remaining Period			2 years 3 months 18 days